Improvement of hepatic steatosis in type 2 diabetic patients treated with a combination of pioglitazone and insulin

被引：0
|
作者：
Zib, Ivana
Salas, Naomi
Raskin, Philip
Szczepaniak, Lidia S.
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [31] The efficacy and durability of exenatide in combination with pioglitazone versus basal bolus insulin in poorly controlled type 2 diabetic patients: the QATAR study
    Abdul-Ghani, M.
    Migahid, O.
    Migahid, A.
    Hassoun, S.
    Alkasem, M.
    Zirie, M.
    DeFronzo, R. A.
    Jayyousi, A.
    DIABETOLOGIA, 2016, 59 : S379 - S379
  • [32] Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients
    Güvener, N
    Gedik, O
    ACTA DIABETOLOGICA, 1999, 36 (1-2) : 93 - 97
  • [33] Efficacy of pioglitazone on type 2 diabetic patients with hemodialysis
    Abe, Masanori
    Kikuchi, Fumito
    Okada, Kazuyoshi
    Kaizu, Kazo
    Matsumoto, Koichi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (03) : 432 - 438
  • [34] Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
    Lavynenko, Olga
    Abdul-Ghani, Muhammad
    Alatrach, Mariam
    Puckett, Curtiss
    Adams, John
    Abdelgani, Siham
    Alkhouri, Naim
    Triplitt, Curtis
    Clarke, Geoffrey D.
    Vasquez, Juan A.
    Li, Jinqi
    Cersosimo, Eugenio
    Gastaldelli, Amalia
    DeFronzo, Ralph A.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 899 - 907
  • [35] Pioglitazone in type-2-diabetic patients with nephropathy
    Froehling, P.
    Ringel, J.
    Brandt, E.
    Krupki, F.
    Luebben, G.
    Karagiannis, E.
    DIABETES, 2006, 55 : A501 - A501
  • [36] The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin
    Tooke, JE
    Elston, LM
    Gooding, KM
    Ball, CI
    Mawson, DM
    Piper, J
    Sriraman, R
    Urquhart, R
    Shore, AC
    DIABETOLOGIA, 2006, 49 (05) : 1064 - 1070
  • [37] Progression of retinopathy in insulin-treated type 2 diabetic patients
    Henricsson, M
    Berntorp, K
    Fernlund, P
    Sundkvist, G
    DIABETES CARE, 2002, 25 (02) : 381 - 385
  • [38] Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin
    Araki, Takahiro
    Emoto, Masanori
    Teramura, Megumi
    Yokoyama, Hisayo
    Mori, Katsuhito
    Hatsuda, Sawako
    Maeno, Takaaki
    Shinohara, Kayo
    Koyama, Hidenori
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (08): : 996 - 1001
  • [39] Troglitazone use in insulin-treated type 2 diabetic patients
    Buse, JB
    Gumbiner, B
    Mathias, NP
    Nelson, DM
    Faja, BW
    Whitcomb, RW
    DIABETES CARE, 1998, 21 (09) : 1455 - 1461
  • [40] The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin
    J. E. Tooke
    L. M. Elston
    K. M. Gooding
    C. I. Ball
    D. M. Mawson
    J. Piper
    R. Sriraman
    R. Urquhart
    A. C. Shore
    Diabetologia, 2006, 49
12345